Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing SpectrumAnn Neurol 87:659-669, Dubey, D.,et al, 2020
Monoclonal Antibody Therapies and Neurologic DisordersArch Neurol 65:1162-1165, Novack,J.C.,et al., 2008